SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-026244
Filing Date
2021-10-25
Accepted
2021-10-25 16:43:25
Documents
114

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 5650323
2 forms-1_001.jpg GRAPHIC 4983
3 forms-1_002.jpg GRAPHIC 21492
4 forms-1_003.jpg GRAPHIC 15060
5 ex5-1.htm EX-5.1 29573
6 ex10-44.htm EX-10.44 111826
7 ex10-45.htm EX-10.45 113234
8 ex21-1.htm EX-21.1 4273
9 ex23-2.htm EX-23.2 5714
10 ex23-3.htm EX-23.3 3865
  Complete submission text file 0001493152-21-026244.txt   21611217

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE ensc-20210630.xsd EX-101.SCH 100352
12 XBRL CALCULATION FILE ensc-20210630_cal.xml EX-101.CAL 105412
13 XBRL DEFINITION FILE ensc-20210630_def.xml EX-101.DEF 745201
14 XBRL LABEL FILE ensc-20210630_lab.xml EX-101.LAB 682611
15 XBRL PRESENTATION FILE ensc-20210630_pre.xml EX-101.PRE 754951
16 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 4435455
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-260478 | Film No.: 211344617
SIC: 2834 Pharmaceutical Preparations